Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 23 of about 9 companies and 14 funds for Gene Douglas�
Company Exchange Symbol Last price Quote change Market cap
Qiagen NV NASDAQ QGEN 22.84 -0.07 (-0.31%) 5.47B
QIAGEN NV, (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated ...
GenVec Inc NASDAQ GNVC 1.73 +0.02 (1.17%) 29.88M
GenVec, Inc. develops gene-based pharmaceuticals and therapies for the treatment of major medical needs. The Company combines its patented gene transfer ...
Precision Drilling Corp (USA) NYSE PDS 8.85 -0.18 (-1.99%) 2.64B
Precision Drilling Corporation (Precision) is a provider of contract drilling and completion and production services primarily to oil and natural gas ...
Executive:
Gene C. Stahl
Precision Drilling Corporation TSE PD 9.95 -0.19 (-1.87%) 2.91B
Precision Drilling Corporation (Precision) is a provider of contract drilling and completion and production services primarily to oil and natural gas ...
Executive:
Gene C. Stahl
Applied Micro Circuits Corporation NASDAQ AMCC 6.80 -0.10 (-1.45%) 546.79M
The Company's products include the X-Gene ARM 64 bit Server on a Chip solution, along with the X-WeaveTM family of connectivity products, ...
Qiagen NV ETR QIA 18.05 -0.01 (-0.03%) 4.33B
QIAGEN NV, (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated ...
Qiagen NV FRA QIA 18.02 +0.10 (0.57%) 4.35B
QIAGEN NV, (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated ...
Assurant, Inc. NYSE AIZ 65.59 +1.05 (1.63%) 4.63B
Assurant, Inc. (Assurant) is a provider of specialized insurance products and related services in North America and select worldwide markets.
Executive:
Gene E. Mergelmeyer
Critical Outcome Technologies Inc. CVE COT 0.260 -0.025 (-8.77%) 27.52M
Critical Outcome Technologies Inc. (COTI) is a biotechnology company focused on applying its computer-based technology, CHEMSAS, to identify, profile, ...
Executive:
Gene Kelly
Mutual Fund Symbol Nav Nav change
American Beacon Small Cap Value Fund Class Institutional AVFIX 26.67 +0.42 (1.60%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Investor Class AVPAX 25.87 +0.42 (1.65%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Investor Class AAEPX 11.80 -0.03 (-0.25%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class AMR AAMRX 12.12 -0.03 (-0.25%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class A AEMAX 11.80 -0.03 (-0.25%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Advisor Class AASSX 25.61 +0.40 (1.59%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class Y ABSYX 26.41 +0.42 (1.62%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class A ABSAX 25.55 +0.41 (1.63%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class AMR AASVX 26.62 +0.43 (1.64%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class Institutional AEMFX 12.02 -0.03 (-0.25%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund C Class AEMCX 11.68 -0.03 (-0.26%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class Y ACEYX 12.07 -0.04 (-0.33%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class R ASCVX 25.13 +0.40 (1.62%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund C Class ASVCX 25.00 +0.40 (1.63%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.